Z1TS34.SA Zoetis Inc.

Healthcare Pharmaceuticals Sao Paulo Exchange
31.42 BRL
Close of Nov 5, 2026
21.84 44.28
Market cap
BRL 208B
P/E
15.6x
P/B
11.03x
ROE
82.1%
Dividend yield
1.54%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is Z1TS34.SA undervalued?

Graham number
Price31.42
Graham value11.35
Premium176.8%

Z1TS34.SA trades 176.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zoetis Inc. fundamental analysis

No fundamental analysis for Zoetis Inc. yet.

Zoetis Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also …

Full company profile